Eyenovia Rebrands to Hyperion DeFi, Focuses on Crypto

Eyenovia ( (EYEN) ) has shared an announcement.

On July 1, 2025, Hyperion DeFi, Inc. announced a corporate rebranding from Eyenovia, Inc., reflecting its new focus on a cryptocurrency treasury reserve strategy centered on the HYPE token. The company’s shares will trade under the new ticker symbol ‘HYPD’ on Nasdaq starting July 3, 2025. This strategic shift is part of Hyperion DeFi’s vision to become a leading holder of the HYPE token and a pioneer in digital currency as a treasury asset. Additionally, the company launched the Kinetiq x Hyperion validator to enhance its onchain engagement strategies.

The most recent analyst rating on (EYEN) stock is a Buy with a $560.00 price target. To see the full list of analyst forecasts on Eyenovia stock, see the EYEN Stock Forecast page.

Spark’s Take on EYEN Stock

According to Spark, TipRanks’ AI Analyst, EYEN is a Underperform.

Eyenovia’s stock is heavily weighed down by poor financial performance, including significant operational losses and a weak balance sheet. While there is revenue growth, the negative equity and insufficient cash flow generation are critical risks. Technical indicators also point to a bearish trend, and the valuation metrics are unappealing due to a negative P/E ratio and absence of dividends. These factors result in a low overall score.

To see Spark’s full report on EYEN stock, click here.

More about Eyenovia

Hyperion DeFi, Inc., formerly known as Eyenovia, Inc., is a publicly listed U.S. company pioneering in the development of ophthalmic technologies and building a strategic treasury of Hyperliquid’s native token, HYPE. The company focuses on providing shareholders with access to the Hyperliquid ecosystem and is also developing the Optejet User Filled Device for ophthalmic applications.

Average Trading Volume: 4,433,994

Technical Sentiment Signal: Sell

Current Market Cap: $30.44M

For an in-depth examination of EYEN stock, go to TipRanks’ Overview page.